Indefinite Delivery Contract SPE2DR25D9640

This Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business, aims to provide a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of military healthcare facilities and veterans' medical centers nationwide. The $499,999,999 single-award IDC, valid through November 2026, enables DLA to issue firm fixed-price delivery orders for branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables across various product categories such as injections, tablets, creams, auto-injectors, and specialty medications.

The IDC is part of DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a multi-award procurement with an estimated total value of $30.3 billion. The program will establish Prime Vendor Contracts to provide worldwide pharmaceutical support to the Defense Health Agency, Department of Defense, United States Coast Guard, and other government agencies, including for normal day-to-day operations, planned and unplanned contingency, and war readiness materiel support in both CONUS and OCONUS locations. The unrestricted, fully competitive solicitation will be awarded on a regional basis, with at least three different contractors selected across the North/EUCOM, West/PACOM, South/SOUTHCOM, and Fleet line items.